Literature DB >> 11595492

The cell biology of Alzheimer's disease: uncovering the secrets of secretases.

J Walter1, C Kaether, H Steiner, C Haass.   

Abstract

Progress has been made in characterizing the secretases involved in endoproteolytic processing of the beta-amyloid precursor protein - the precursor of the amyloid beta-peptide (Abeta), which is the main constituent of amyloid plaques that form in the brains of patients with Alzheimer's disease. It is now thought that Abeta is pivotal in the pathogenesis of Alzheimer's disease, and that reducing brain Abeta levels may help to treat or prevent the disease. Two essential factors for the proteolytic generation of Abeta have been identified, beta-secretase and the presenilins, which might aid the design of drugs against this disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11595492     DOI: 10.1016/s0959-4388(00)00253-1

Source DB:  PubMed          Journal:  Curr Opin Neurobiol        ISSN: 0959-4388            Impact factor:   6.627


  35 in total

1.  Presenilin and nicastrin regulate each other and determine amyloid beta-peptide production via complex formation.

Authors:  Dieter Edbauer; Edith Winkler; Christian Haass; Harald Steiner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-04       Impact factor: 11.205

Review 2.  Furin at the cutting edge: from protein traffic to embryogenesis and disease.

Authors:  Gary Thomas
Journal:  Nat Rev Mol Cell Biol       Date:  2002-10       Impact factor: 94.444

Review 3.  Hemopressin and other bioactive peptides from cytosolic proteins: are these non-classical neuropeptides?

Authors:  Julia S Gelman; Lloyd D Fricker
Journal:  AAPS J       Date:  2010-04-10       Impact factor: 4.009

Review 4.  Disease-modifying therapies in Alzheimer's disease: how far have we come?

Authors:  Michael Hüll; Mathias Berger; Michael Heneka
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 5.  Role of APP Interactions with Heterotrimeric G Proteins: Physiological Functions and Pathological Consequences.

Authors:  Philip F Copenhaver; Donat Kögel
Journal:  Front Mol Neurosci       Date:  2017-01-31       Impact factor: 5.639

Review 6.  Genetics of Alzheimer disease.

Authors:  Lynn M Bekris; Chang-En Yu; Thomas D Bird; Debby W Tsuang
Journal:  J Geriatr Psychiatry Neurol       Date:  2010-12       Impact factor: 2.680

7.  BACE1 retrograde trafficking is uniquely regulated by the cytoplasmic domain of sortilin.

Authors:  Gina M Finan; Hirokazu Okada; Tae-Wan Kim
Journal:  J Biol Chem       Date:  2011-01-18       Impact factor: 5.157

8.  Trehalose Alters Subcellular Trafficking and the Metabolism of the Alzheimer-associated Amyloid Precursor Protein.

Authors:  Nguyen T Tien; Ilker Karaca; Irfan Y Tamboli; Jochen Walter
Journal:  J Biol Chem       Date:  2016-03-08       Impact factor: 5.157

9.  Deficiency of sphingosine-1-phosphate lyase impairs lysosomal metabolism of the amyloid precursor protein.

Authors:  Ilker Karaca; Irfan Y Tamboli; Konstantin Glebov; Josefine Richter; Lisa H Fell; Marcus O Grimm; Viola J Haupenthal; Tobias Hartmann; Markus H Gräler; Gerhild van Echten-Deckert; Jochen Walter
Journal:  J Biol Chem       Date:  2014-05-07       Impact factor: 5.157

10.  Retention in endoplasmic reticulum 1 (RER1) modulates amyloid-β (Aβ) production by altering trafficking of γ-secretase and amyloid precursor protein (APP).

Authors:  Hyo-Jin Park; Daniil Shabashvili; Michael D Nekorchuk; Eva Shyqyriu; Joo In Jung; Thomas B Ladd; Brenda D Moore; Kevin M Felsenstein; Todd E Golde; Seong-Hun Kim
Journal:  J Biol Chem       Date:  2012-10-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.